GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Days Inventory

IXICO (LSE:IXI) Days Inventory : 0.00 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is IXICO Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). IXICO's Average Total Inventories for the six months ended in Mar. 2024 was £0.00 Mil. IXICO's Cost of Goods Sold for the six months ended in Mar. 2024 was £1.52 Mil. Hence, IXICO's Days Inventory for the six months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for IXICO's Days Inventory or its related term are showing as below:

LSE:IXI's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 193.86
* Ranked among companies with meaningful Days Inventory only.

IXICO's Days Inventory stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. IXICO's Inventory-to-Revenue for the six months ended in Mar. 2024 was 0.00.


IXICO Days Inventory Historical Data

The historical data trend for IXICO's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IXICO Days Inventory Chart

IXICO Annual Data
Trend Sep13 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IXICO Semi-Annual Data
Mar14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IXICO's Days Inventory

For the Biotechnology subindustry, IXICO's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IXICO's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IXICO's Days Inventory distribution charts can be found below:

* The bar in red indicates where IXICO's Days Inventory falls into.



IXICO Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

IXICO's Days Inventory for the fiscal year that ended in Sep. 2023 is calculated as

Days Inventory (A: Sep. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Sep. 2022 ) + Total Inventories (A: Sep. 2023 )) / count ) / Cost of Goods Sold (A: Sep. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 3.395*365
=0 / 3.395*365
=0.00

IXICO's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

Days Inventory (Q: Mar. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 1.518*365 / 2
=0 / 1.518*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IXICO  (LSE:IXI) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

IXICO's Inventory Turnover for the six months ended in Mar. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

IXICO's Inventory to Revenue for the six months ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


IXICO Days Inventory Related Terms

Thank you for viewing the detailed overview of IXICO's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


IXICO (LSE:IXI) Business Description

Traded in Other Exchanges
Address
15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO (LSE:IXI) Headlines

No Headlines